A structure-based approach to designing non-natural peptides that can activate anti-melanoma cytotoxic T cells.

about

Structural insights into the binding of hepatitis B virus core peptide to HLA-A2 alleles: towards designing better vaccines Quantitative approaches to computational vaccinology.Antigen kinetics determines immune reactivity.Peptidomimetics: modifying peptides in the pursuit of better vaccines.

P2860

Q27667663-7AB0E2F3-0E60-4F52-B9B6-46A82B038D55 Q34687630-1AB14022-38C3-46EC-A4A4-5109928FAA80 Q36516144-E9561ED1-40E0-436B-A165-C38BEABF0641 Q37844539-E2705516-A869-47F3-8B58-8BC78AAA047C

P2860

A structure-based approach to designing non-natural peptides that can activate anti-melanoma cytotoxic T cells.

Item

http://www.wikidata.org/entity/Q40963061

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

1999年论文

@zh

1999年论文

@zh-cn

name

A structure-based approach to ...... ti-melanoma cytotoxic T cells.

@en

type

Item

label

A structure-based approach to ...... ti-melanoma cytotoxic T cells.

@en

prefLabel

A structure-based approach to ...... ti-melanoma cytotoxic T cells.

@en

P1476

A structure-based approach to ...... nti-melanoma cytotoxic T cells

@en

P2093

B Monsarrat

http://www.w3.org/2001/XMLSchema#string

B Van den Eynde

http://www.w3.org/2001/XMLSchema#string

H Mazarguil

http://www.w3.org/2001/XMLSchema#string

J E Gairin

http://www.w3.org/2001/XMLSchema#string

P2860

Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex

A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma

Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2

Structure of the complex between human T-cell receptor, viral peptide and HLA-A2

The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product

Rational design of nonnatural peptides as high-affinity ligands for the HLA-B*2705 human leukocyte antigen

Antigenic mimicry of natural L-peptides with retro-inverso-peptidomimetics

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.

P304

10227-10234

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.274.15.10227

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

274

http://www.w3.org/2001/XMLSchema#string

P50

Maha Ayyoub

P577

1999-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13109938

http://www.w3.org/2001/XMLSchema#string

P698

10187808

http://www.w3.org/2001/XMLSchema#string

A structure-based approach to designing non-natural peptides that can activate anti-melanoma cytotoxic T cells.

about

P2860

P2860

A structure-based approach to designing non-natural peptides that can activate anti-melanoma cytotoxic T cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698